Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -40.88%3.97B | 7,820.69%6.72B | -101.92%-87M | 359.05%4.54B | -78.22%989M | 94.10%4.54B | -1.60%2.34B | -32.53%2.38B | 396.55%3.52B | -239.60%-1.19B |
Net profit before non-cash adjustment | 105.55%4.34B | 198.44%2.11B | 297.19%707M | -95.06%178M | 74.38%3.6B | 36.94%2.07B | -2.52%1.51B | -10.89%1.55B | 5.02%1.74B | 277.55%1.65B |
Total adjustment of non-cash items | -38.82%1.79B | 40.95%2.93B | -7.64%2.08B | 823.47%2.25B | -115.16%-311M | -12.79%2.05B | 71.38%2.35B | -9.43%1.37B | 321.64%1.52B | -127.67%-684M |
-Depreciation and amortization | -6.79%1.91B | 2.14%2.05B | -9.68%2.01B | -6.41%2.22B | 12.90%2.37B | 18.57%2.1B | 31.85%1.77B | 0.15%1.34B | 3.79%1.34B | -4.65%1.29B |
-Reversal of impairment losses recognized in profit and loss | --0 | --690M | --0 | ---- | ---- | -65.74%160M | --467M | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 77.82%-108M | -259.15%-487M |
-Share of associates | 84.62%48M | 160.00%26M | -47.37%10M | -13.64%19M | 4.76%22M | --21M | ---- | ---- | ---- | ---- |
-Disposal profit | -3,275.00%-135M | 91.84%-4M | 52.88%-49M | 96.47%-104M | ---2.95B | --0 | ---- | -430.00%-33M | 106.10%10M | -1,390.91%-164M |
-Net exchange gains and losses | -153.66%-208M | -171.30%-82M | -41.92%115M | 453.57%198M | ---56M | ---- | ---- | ---- | ---- | ---- |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -137.80%-31M | --82M |
-Other non-cash items | -29.08%178M | 8,466.67%251M | 96.39%-3M | -127.76%-83M | 230.00%299M | -301.75%-230M | 83.87%114M | -79.54%62M | 121.52%303M | -271.50%-1.41B |
Changes in working capital | -228.56%-2.16B | 158.45%1.68B | -235.84%-2.87B | 191.87%2.11B | -646.08%-2.3B | 127.62%421M | -180.15%-1.52B | -300.74%-544M | 112.56%271M | -212.61%-2.16B |
-Change in receivables | -66.57%334M | 2,800.00%999M | -107.96%-37M | -40.91%465M | 192.05%787M | 57.34%-855M | -364.97%-2B | -302.35%-431M | 123.46%213M | -148.09%-908M |
-Change in inventory | -714.69%-1.17B | 94.13%-143M | -326.09%-2.44B | 191.43%1.08B | -306.21%-1.18B | 43.14%-290M | 9.41%-510M | -502.14%-563M | 114.66%140M | -568.14%-955M |
-Change in payables | -173.60%-1.07B | 884.35%1.45B | 183.52%147M | 91.36%-176M | -234.43%-2.04B | 61.62%1.52B | 51.05%938M | 857.32%621M | 72.11%-82M | 44.32%-294M |
-Provision for loans, leases and other losses | 98.50%-3M | 20.00%-200M | -147.98%-250M | 513.49%521M | -209.57%-126M | --115M | --0 | ---248M | ---- | ---- |
-Changes in other current assets | 207.76%500M | -57.82%-464M | -230.67%-294M | -12.11%225M | 493.85%256M | -225.00%-65M | -32.47%52M | --77M | ---- | ---- |
-Changes in other current liabilities | -2,092.11%-757M | --38M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -14.94%-200M | -26.09%-174M | -10.40%-138M | 37.50%-125M | -12.36%-200M | -131.17%-178M | -32.76%-77M | 7.94%-58M | 20.25%-63M | -19.70%-79M |
Interest received (cash flow from operating activities) | 17.02%55M | 67.86%47M | -26.32%28M | -55.81%38M | 168.75%86M | -21.95%32M | 17.14%41M | -28.57%35M | -15.52%49M | -6.45%58M |
Tax refund paid | -101.86%-652M | 60.85%-323M | 14.60%-825M | -19.70%-966M | -3.46%-807M | -101.55%-780M | 8.73%-387M | -57.62%-424M | -14.47%-269M | -360.78%-235M |
Other operating cash inflow (outflow) | -1M | 0 | 1M | 0 | -175.50%-114M | 15,000.00%151M | 1M | 0 | 1M | 0 |
Operating cash flow | -49.37%3.17B | 713.81%6.27B | -129.28%-1.02B | 7,680.43%3.49B | -101.22%-46M | 96.40%3.77B | -0.67%1.92B | -40.45%1.93B | 324.45%3.24B | -281.64%-1.44B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 34.56%-873M | 66.87%-1.33B | -191.11%-4.03B | -473.86%-1.38B | 93.49%-241M | -143.81%-3.7B | 26.77%-1.52B | -23.39%-2.07B | -5.26%-1.68B | -22.86%-1.6B |
Net intangibles purchase and sale | 42.86%-112M | -1,681.82%-196M | 73.81%-11M | 51.72%-42M | 45.63%-87M | 12.57%-160M | -251.92%-183M | 10.34%-52M | -65.71%-58M | -118.75%-35M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | 11.96%-1.31B | ---1.49B | ---- | ---- |
Net investment product transactions | -24.59%138M | 218.83%183M | -141.96%-154M | 321.08%367M | -492.86%-166M | -264.71%-28M | 206.25%17M | -245.45%-16M | -98.80%11M | 743.12%919M |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | 0.00%2M | 100.00%2M | -50.00%1M | 0.00%2M | 100.00%2M | -90.00%1M |
Net changes in other investments | 205.17%122M | -11,700.00%-116M | -97.44%1M | 225.00%39M | -82.61%12M | 40.82%69M | 206.52%49M | -120.00%-46M | 96.58%230M | 134.00%117M |
Investing cash flow | 50.44%-725M | 65.08%-1.46B | -311.19%-4.19B | -112.29%-1.02B | 87.43%-480M | -29.69%-3.82B | 19.85%-2.94B | -145.69%-3.67B | -151.68%-1.5B | 48.17%-594M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 37.75%-1.56B | -243.24%-2.51B | 3,995.56%1.75B | -103.70%-45M | 48.84%1.22B | 25.31%817M | -69.94%652M | 384.27%2.17B | -218.29%-763M | 93.11%645M |
Net common stock issuance | ---2M | --0 | --0 | --0 | 66.67%-1M | 98.20%-3M | -8,250.00%-167M | 50.00%-2M | -33.33%-4M | -100.60%-3M |
Increase or decrease of lease financing | 5.41%-35M | -208.33%-37M | 50.00%-12M | -60.00%-24M | -25.00%-15M | 40.00%-12M | 13.04%-20M | 14.81%-23M | -8.00%-27M | 24.24%-25M |
Cash dividends paid | -100.00%-300M | ---150M | ---- | 44.24%-150M | -12.55%-269M | -32.04%-239M | 0.00%-181M | -19.87%-181M | ---151M | ---- |
Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 20.00%-4M | ---5M | ---- |
Net other fund-raising expenses | 50.00%-1M | 33.33%-2M | -50.00%-3M | 33.33%-2M | 0.00%-3M | -50.00%-3M | 33.33%-2M | -200.00%-3M | 50.00%-1M | -100.00%-2M |
Financing cash flow | 29.59%-1.9B | -255.35%-2.7B | 886.43%1.74B | -123.81%-221M | 65.71%928M | 98.58%560M | -85.58%282M | 305.68%1.96B | -254.63%-951M | -23.32%615M |
Net cash flow | ||||||||||
Beginning cash position | 101.83%4.4B | -60.87%2.18B | 68.30%5.57B | 12.61%3.31B | 18.59%2.94B | -22.96%2.48B | 2.42%3.22B | 25.57%3.14B | -34.27%2.5B | 22.80%3.81B |
Current changes in cash | -74.00%547M | 160.58%2.1B | -254.56%-3.47B | 458.96%2.25B | -20.71%402M | 168.05%507M | -449.77%-745M | -73.21%213M | 155.87%795M | -415.52%-1.42B |
Effect of exchange rate changes | 163.79%306M | 45.00%116M | 433.33%80M | 150.00%15M | 34.78%-30M | -1,020.00%-46M | 103.68%5M | 11.69%-136M | -231.62%-154M | -54.12%117M |
Cash adjustments other than cash changes | ---- | --1M | ---- | ---- | ---1M | ---- | 200.00%1M | 0.00%-1M | -200.00%-1M | 0.00%1M |
End cash Position | 19.38%5.26B | 101.83%4.4B | -60.87%2.18B | 68.30%5.57B | 12.61%3.31B | 18.59%2.94B | -22.96%2.48B | 2.42%3.22B | 25.57%3.14B | -34.27%2.5B |
Free cash flow | -52.38%2.16B | 185.46%4.54B | -380.40%-5.31B | 159.19%1.89B | -2,680.87%-3.2B | 94.58%-115M | -540.79%-2.12B | -122.02%-331M | 148.88%1.5B | -491.35%-3.08B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |